» Articles » PMID: 35364023

Risk of Hospitalisation and Death in Children with SARS-CoV-2 Delta (B.1.612.2) Infection

Overview
Specialty Pediatrics
Date 2022 Apr 1
PMID 35364023
Authors
Affiliations
Soon will be listed here.
Citing Articles

Impact of vaccination on the association of COVID-19 with cardiovascular diseases: An OpenSAFELY cohort study.

Cezard G, Denholm R, Knight R, Wei Y, Teece L, Toms R Nat Commun. 2024; 15(1):2173.

PMID: 38467603 PMC: 10928172. DOI: 10.1038/s41467-024-46497-0.


The impact of immunocompromise on outcomes of COVID-19 in children and young people-a systematic review and meta-analysis.

Greenan-Barrett J, Aston S, Deakin C, Ciurtin C Front Immunol. 2023; 14:1159269.

PMID: 37691952 PMC: 10485615. DOI: 10.3389/fimmu.2023.1159269.


Pediatric Hospitalizations and ICU Admissions Due to COVID-19 and Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 in England.

Ward J, Harwood R, Kenny S, Cruz J, Clark M, Davis P JAMA Pediatr. 2023; .

PMID: 37523172 PMC: 10391354. DOI: 10.1001/jamapediatrics.2023.2357.


Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity.

Marwali E, Kekalih A, Yuliarto S, Wati D, Rayhan M, Valerie I BMJ Paediatr Open. 2023; 6(1).

PMID: 36645791 PMC: 9621167. DOI: 10.1136/bmjpo-2022-001657.


COVID-19 deaths in children and young people in England, March 2020 to December 2021: An active prospective national surveillance study.

Bertran M, Amin-Chowdhury Z, Davies H, Allen H, Clare T, Davison C PLoS Med. 2022; 19(11):e1004118.

PMID: 36346784 PMC: 9642873. DOI: 10.1371/journal.pmed.1004118.


References
1.
Viner R, Mytton O, Bonell C, Melendez-Torres G, Ward J, Hudson L . Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-analysis. JAMA Pediatr. 2020; 175(2):143-156. PMC: 7519436. DOI: 10.1001/jamapediatrics.2020.4573. View

2.
Twohig K, Nyberg T, Zaidi A, Thelwall S, Sinnathamby M, Aliabadi S . Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infect Dis. 2021; 22(1):35-42. PMC: 8397301. DOI: 10.1016/S1473-3099(21)00475-8. View

3.
Powell A, Kirsebom F, Stowe J, McOwat K, Saliba V, Ramsay M . Effectiveness of BNT162b2 against COVID-19 in adolescents. Lancet Infect Dis. 2022; 22(5):581-583. PMC: 8937250. DOI: 10.1016/S1473-3099(22)00177-3. View

4.
Molteni E, Sudre C, Dos Santos Canas L, Bhopal S, Hughes R, Chen L . Illness Characteristics of COVID-19 in Children Infected with the SARS-CoV-2 Delta Variant. Children (Basel). 2022; 9(5). PMC: 9140086. DOI: 10.3390/children9050652. View